Galer Bradley S.

Avg. Two Year Performance

24% Avg. Purchase Return

11% Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	13%	30%	19%	10%	24%
Purchase Success Rate	2 of 2	2 of 2	2 of 2	1 of 2	1 of 2
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Zogenix, Inc.

Drugs » Drug Manufacturers - Major

EVP & Chief Medical Officer:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--